Patricia Pavelkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Patricia Pavelkova has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Barbora Kalocayova
Centre of Experimental Medicine, Slovak Academy of Sciences, 841 04 Bratislava, Slovakia
3 shared publications - Branislav Kura
Centre of Experimental Medicine Slovak Academy of Sciences
3 shared publications - Jan Slezak
Slovak Academy of Sciences
3 shared publications - Margita Pobijakova
Bory Hospital – Penta Hospitals
2 shared publications - Andrea Šagátová
Institute of Nuclear and Physical Engineering, Faculty of Electrical Engineering and Information Technology, Slovak University of Technology, Ilkovičova 3, SK-841 04 Bratislava, Slovak Republic
1 shared publication - Jana Vlkovicova
Slovak Academy of Sciences
1 shared publication
Latest Publications
- 1 January 2026
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 104, 1-13
Comparison of hydrogen administration methods in the treatment of radiation-induced heart disease in rats
Ionizing radiation is a known risk factor for the occurrence and development of cardiovascular diseases, particularly in patients receiving thoracic radiotherapy. This exposure leads to oxidative stress and inflammation, which can damage cardiac tissue and vascular endothelium. Molecular hydrogen (H 2 ) has been recognized for its therapeutic potential, including antioxidant effects. In this study, male Wistar rats were irradiated with a dose of 10 Gy (X-rays) in the chest area. Two and 9 days post-irradiation, significant increases in lactate dehydrogenase (LDH), catalase, glutathione peroxidase activity, malondialdehyde, superoxide, and tumor necrosis factor alpha levels were observed in the rat blood plasma or heart tissue. Administration of H 2 either via drinking H 2 -rich water (min. 4 mg/L) or inhaling H 2 in air (4%), effectively decreased oxidative stress, LDH, and inflammatory proteins to normal levels. H 2 also normalized the nuclear factor erythroid 2-related factor 2/Kelch-like ECH-associating protein 1 (Nrf2/Keap1) pathway, an important antioxidative response regulator activated by irradiation. Based on these results, we can conclude that H 2 administration through both routes mitigated heart damage caused by irradiation after 2 and 9 days. The mitigating effect exerted more pronounced trend with H 2 gas inhalation, but further research is needed for statistically relevant data and mechanistic insights.
- 1 January 2026
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 104, 1-13
Comparison of hydrogen administration methods in the treatment of radiation-induced heart disease in rats
Ionizing radiation is a known risk factor for the occurrence and development of cardiovascular diseases, particularly in patients receiving thoracic radiotherapy. This exposure leads to oxidative stress and inflammation, which can damage cardiac tissue and vascular endothelium. Molecular hydrogen (H 2 ) has been recognized for its therapeutic potential, including antioxidant effects. In this study, male Wistar rats were irradiated with a dose of 10 Gy (X-rays) in the chest area. Two and 9 days post-irradiation, significant increases in lactate dehydrogenase (LDH), catalase, glutathione peroxidase activity, malondialdehyde, superoxide, and tumor necrosis factor alpha levels were observed in the rat blood plasma or heart tissue. Administration of H 2 either via drinking H 2 -rich water (min. 4 mg/L) or inhaling H 2 in air (4%), effectively decreased oxidative stress, LDH, and inflammatory proteins to normal levels. H 2 also normalized the nuclear factor erythroid 2-related factor 2/Kelch-like ECH-associating protein 1 (Nrf2/Keap1) pathway, an important antioxidative response regulator activated by irradiation. Based on these results, we can conclude that H 2 administration through both routes mitigated heart damage caused by irradiation after 2 and 9 days. The mitigating effect exerted more pronounced trend with H 2 gas inhalation, but further research is needed for statistically relevant data and mechanistic insights.
- Open Access
- 6 July 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (7) , 7097-7113
MicroRNAs as Regulators of Radiation-Induced Oxidative Stress
MicroRNAs (miRNAs) represent small RNA molecules involved in the regulation of gene expression. They are implicated in the regulation of diverse cellular processes ranging from cellular homeostasis to stress responses. Unintended irradiation of the cells and tissues, e.g., during medical uses, induces various pathological conditions, including oxidative stress. miRNAs may regulate the expression of transcription factors (e.g., nuclear factor erythroid 2 related factor 2 (Nrf2), nuclear factor kappa B (NF-κB), tumor suppressor protein p53) and other redox-sensitive genes (e.g., mitogen-activated protein kinase (MAPKs), sirtuins (SIRTs)), which trigger and modulate cellular redox signaling. During irradiation, miRNAs mainly act with reactive oxygen species (ROS) to regulate the cell fate. Depending on the pathway involved and the extent of oxidative stress, this may lead to cell survival or cell death. In the context of radiation-induced oxidative stress, miRNA-21 and miRNA-34a are among the best-studied miRNAs. miRNA-21 has been shown to directly target superoxide dismutase (SOD), or NF-κB, whereas miRNA-34a is a direct regulator of NADPH oxidase (NOX), SIRT1, or p53. Understanding the mechanisms underlying radiation-induced injury including the involvement of redox-responsive miRNAs may help to develop novel approaches for modulating the cellular response to radiation exposure.
- 6 July 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (7) , 7097-7113
Open AccessMicroRNAs as Regulators of Radiation-Induced Oxidative Stress
MicroRNAs (miRNAs) represent small RNA molecules involved in the regulation of gene expression. They are implicated in the regulation of diverse cellular processes ranging from cellular homeostasis to stress responses. Unintended irradiation of the cells and tissues, e.g., during medical uses, induces various pathological conditions, including oxidative stress. miRNAs may regulate the expression of transcription factors (e.g., nuclear factor erythroid 2 related factor 2 (Nrf2), nuclear factor kappa B (NF-κB), tumor suppressor protein p53) and other redox-sensitive genes (e.g., mitogen-activated protein kinase (MAPKs), sirtuins (SIRTs)), which trigger and modulate cellular redox signaling. During irradiation, miRNAs mainly act with reactive oxygen species (ROS) to regulate the cell fate. Depending on the pathway involved and the extent of oxidative stress, this may lead to cell survival or cell death. In the context of radiation-induced oxidative stress, miRNA-21 and miRNA-34a are among the best-studied miRNAs. miRNA-21 has been shown to directly target superoxide dismutase (SOD), or NF-κB, whereas miRNA-34a is a direct regulator of NADPH oxidase (NOX), SIRT1, or p53. Understanding the mechanisms underlying radiation-induced injury including the involvement of redox-responsive miRNAs may help to develop novel approaches for modulating the cellular response to radiation exposure.
- 17 February 2024
- Published by Springer Nature
- p. 125-143
Radiation-Induced Heart Disease: Potential Role for Molecular Hydrogen
- 17 February 2024
- Published by Springer Nature
- p. 125-143
Radiation-Induced Heart Disease: Potential Role for Molecular Hydrogen